Addiction Treatment
Objective evidence, delivered with dignity.
Monitoring is the backbone of trust in a treatment program. Cadence provides PEth, EtG, and CDT alcohol biomarkers alongside an expanded 17-drug urine panel — every result confirmed, documented, and reported with clinical context your counselors can actually use.
The challenges we solve
Self-reported abstinence without lab confirmation
Faxed results arriving days after a program milestone
Chain-of-custody paperwork that slows intake
The Cadence line for your practice
A curated set of panels mapped to this practice area, each with physician-readable reporting and 24–48 hour standard turnaround.
Alcohol Use Biomarkers
Objective, windowed alcohol-consumption markers for abstinence and treatment monitoring.
Expanded Urine Drug Panel
17-drug screening panel with confirmatory testing for treatment-program compliance.
Comprehensive Metabolic Panel
Glucose, electrolytes, kidney and liver enzymes — the foundational snapshot of metabolic health.
High-Sensitivity CRP
Low-grade vascular inflammation marker that refines cardiovascular risk beyond lipids alone.